MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock for...
$9,949,855
Proceeds from issuance of
common stock, net of...
$489,046
Purchase of property and
equipment
-$12,902
Net cash provided by
financing activities
$10,438,901
Net cash used in
investing activities
$12,902
Effect of foreign
exchange rates on cash and...
$604
Net increase
(decrease) in cash and cash...
$6,121,833
Canceled cashflow
$4,330,574
Depreciation and
amortization
$875,667
Inventory write-downs
$37,311
Impairment of long-lived
assets
$32,347
Provision for product
warranties
$29,355
Stock-based compensation
$24,204
Net cash used in
operating activities
-$4,330,574
Canceled cashflow
$998,884
Net loss
-$2,869,640
Accounts payable and
accrued expenses
-$722,398
something is missing
-$612,421
Accounts receivable
$421,700
Other current assets
$362,957
Non-cash other operating
activities
$137,827
Long-term employee
benefit liabilities
-$66,230
Research and development
tax incentive...
$63,428
Operating lease
liabilities
-$63,158
Inventories
$7,223
Non-cash adjustment on
r&d expenditure...
$2,476
Back
Back
Cash Flow
INTELLIGENT BIO SOLUTIONS INC. (INBS)
INTELLIGENT BIO SOLUTIONS INC. (INBS)
source: myfinsight.com